PHARMACEUTICAL COMPOSITION COMPRISING A BIOSYNTHETIC ANALOG OF HUMAN INSULIN, AND ITS USE IN THE TREATMENT OF DIABETES MELLITUS.

摘要

The invention relates to a pharmaceutical composition comprising a recombinant human insulin derivative, and consisting in that it includes an effectively acting amount of the recombinant human insulin derivative of formula (I) or its physiologically acceptable salt, and excipients. The invention relates also to a method of preparation of the composition and its use in the treatment of diabetes mellitus.